Results 1 to 10 of about 1,219 (139)
Linear IGA bullous dermatosis potentially triggered by vaccination [PDF]
International Journal of Immunopathology and Pharmacology, 2022 Linear IgA bullous dermatosis (LABD) is a mucocutaneous autoimmune blistering disease affecting both adults and children. It is caused by IgA antibodies targeting multiple antigens along the basement membrane zone, leading to disruption of dermoepidermal
Alberto Corrà +4 more
doaj +3 more sources
Linear IgA bullous dermatosis–a fifty year experience of Warsaw Center of bullous diseases [PDF]
Frontiers in ImmunologyLinear IgA bullous dermatosis (LABD) is a rare subepidermal blistering disorder characterized by the presence of linear IgA deposits at the basement membrane zone (BMZ) by direct immunofluorescence (DIF). This entity was first described by Chorzelski and
Cezary Kowalewski, Katarzyna Wozniak
doaj +4 more sources
Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system [PDF]
Frontiers in MedicineBackgroundLinear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disease. The induction of LABD by medications is a critical issue, with previous studies highlighting the link between specific drugs and the onset of LABD. This study aims to
Yixuan Yang +5 more
doaj +4 more sources
IgA LINEAR BULLOUS DERMATOSIS IN CHILDHOOD. [PDF]
Journal of IMAB, 2015 IgA linear bullous dermatosis, also known as chronic bullous dermatosis of childhood, is an autoimmune disease which may be idiopathic or drug-induced. The disease affects children and adults.
Ivelina Yordanova +3 more
doaj +3 more sources
Linear IgA and IgG bullous dermatosis [PDF]
Anais Brasileiros de Dermatologia, 2016 Childhood linear immunoglobulin A dermatosis is a rare autoimmune vesiculobullous disease. It results in linear deposition of autoantibodies (immunoglobulin A) against antigens in the basal membrane zone, leading to subepidermal cleavage.
Karina de Almeida Pinto Fernandes +5 more
doaj +3 more sources
Journal of Cutaneous Medicine and Surgery, 2022 Linear IgA bullous dermatosis (LABD) is group of heterogeneous autoimmune subepidermal blistering diseases characterized by exclusively IgA autoantibodies targeting a component of the epidermal basement membrane zone. The laminina-lucida-type LABD, also known as chronic bullous dermatosis of childhood, is a rare disease, yet the most common autoimmune ...
Barbara Horváth, Marcel F. Jonkman
exaly +4 more sources
Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report
Clinical Case Reports, 2022 Linear IgA/IgG bullous dermatosis (LAGBD) is a rare, autoimmune blistering skin disease. We report a case of LAGBD in a 70‐year‐old woman. All common treatments were discontinued due to side effects or lack of treatment response.
Morten Bahrt Haulrig +3 more
doaj +2 more sources
Linear IgA bullous dermatosis and elevated bullous interleukin‐6 levels: Responsive to treatment with Anti‐IL‐6 receptor monoclonals [PDF]
Clinical Case Reports, 2023 Linear IgA bullous dermatosis (LABD) is a rare autoimmune/inflammatory skin condition. Here, we report on a patient who developed treatment resistant LABD. At diagnosis, elevations of IL‐6 and C‐reactive protein in the blood and extreme elevations of IL‐
Stanley C. Jordan +7 more
doaj +2 more sources
Linear IgA bullous dermatosis: 32 years of experience [PDF]
Anais Brasileiros de DermatologiaBackground: Linear IgA bullous dermatosis (LABD) is an uncommon disease with only a few reported studies in large series with long follow-up periods. Objectives: To evaluate the clinical presentation, immunopathological features, management, and disease
Tugba Atci +3 more
doaj +2 more sources
Vestnik Dermatologii i Venerologii, 2019 Aim: to present a clinical case of linear IgA bullous dermatosis.Materials and methods. A 44 years old patient complaining of skin rashes on the trunk and extremities, accompanied by severe itching was examined.
L. F. Znamenskaya +2 more
doaj +5 more sources